Central estrogen inhibition of angiotensin II-induced hypertension in male mice and the role of reactive oxygen species

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 295, Issue 3, 2008, Pages

  Xue, Baojian ^b   Zhao, Yuanzi ^b,d   Johnson, Alan Kim ^a,b,c   Hay, Meredith ^a,b,e  

^a UNIVERSITY OF IOWA   (United States)

^b The University of Iowa   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d Division of Neonatology and Developmental Biology   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

Author keywords

Blood pressure; Oxidative stress; Sex hormone; Subfornical organ

Indexed keywords

ANGIOTENSIN II; ESTRADIOL; FULVESTRANT; IRBESARTAN; REACTIVE OXYGEN METABOLITE; TEMPOL; AMINE OXIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BIPHENYL DERIVATIVE; DRUG DERIVATIVE; ESTROGEN; TETRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; BRAIN SLICE; CONTROLLED STUDY; GANGLION BLOCK; HORMONAL REGULATION; HYPERTENSION; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRESSOR RESPONSE; PRIORITY JOURNAL; SYMPATHETIC INNERVATION; TELEMETRY; TISSUE SECTION; WILD TYPE; ANIMAL; CHEMICALLY INDUCED DISORDER; CONFOCAL MICROSCOPY; DRUG ANTAGONISM; DRUG EFFECT; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SPIN LABELING; STATISTICAL ANALYSIS; SUBFORNICAL ORGAN;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BIPHENYL COMPOUNDS; BLOOD PRESSURE; CYCLIC N-OXIDES; DATA INTERPRETATION, STATISTICAL; ESTRADIOL; ESTROGENS; HYPERTENSION; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MICROSCOPY, CONFOCAL; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SPIN LABELS; SUBFORNICAL ORGAN; TELEMETRY; TETRAZOLES;

EID: 54049139294     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00021.2008     Document Type: Article

References (53)

1. Blumenthal RS, Heldman AW, Brinker JA, Resar JR, Coombs VJ, Gloth ST, Gerstenblith G, Reis SE. Acute effects of conjugated estrogens on coronary blood flow response to acetylcholine in men. Am J Cardiol 80: 1021-1024, 1997.
2. Chao HH, Chen JJ, Chen CH, Lin H, Cheng CF, Lian WS, Chen YL, Juan SH, Liu JC, Liou JY, Chan P, Cheng TH. Inhibition of angiotensin II induced endothelin-1 gene expression by 17-β-oestradiol in rat cardiac fibroblasts. Heart 91: 664-669, 2005.
3. 1 receptor antagonists in subfornical organ-lesioned rats. Clin Exp Pharmacol Physiol 32: 462-466, 2005.
4. Cox BF, Bishop VS. Neural and humoral mechanisms of angiotensin-dependent hypertension. Am J Physiol Heart Circ Physiol 261: H1284-H1291, 1991.
5. Dantas AP, Tostes RC, Fortes ZB, Costa SG, Nigro D, Carvalho MH. In vivo evidence for antioxidant potential of estrogen in microvessels of female spontaneously hypertensive rats. Hypertension 39: 405-411, 2002.
6. Dean SA, Tan J, O'Brien ER, Leenen FH. 17β-Estradiol downregulates tissue angiotensin-converting enzyme and ANG II type 1 receptor in female rats. Am J Physiol Regul Integr Comp Physiol 288: R759-R766, 2005.
7. Falkenstein E, Tillmann HC, Christ M, Feuring M, Wehling M. Multiple actions of steroid hormones: a focus on rapid, nongenomic effects. Pharmacol Rev 52: 513-556, 2000.
8. Ferguson AV, Bains JS. Actions of angiotensin in the subfornical organ and area postrema: implications for long term control of autonomic output. Clin Exp Pharmacol Physiol 24: 96-101, 1997.
9. Ferguson AV, Wall KM. Central actions of angiotensin in cardiovascular control: multiple roles for a single peptide. Can J Physiol Pharmacol 70: 779-785, 1992.
10. Fitzsimons JT. Angiotensin, thirst, and sodium appetite. Physiol Rev 78: 583-686, 1998.
11. Florian M, Freiman A, Magder S. Treatment with 17-beta-estradiol reduces superoxide production in aorta of ovariectomized rats. Steroids 69: 779-787, 2004.
12. Gingerich S, Krukoff TL. Estrogen in the paraventricular nucleus attenuates L-glutamate-induced increases in mean arterial pressure through estrogen receptor beta and NO. Hypertension 48: 1130-1136, 2006.
13. Gragasin FS, Xu Y, Arenas IA, Kainth N, Davidge ST. Estrogen reduces angiotensin II-induced nitric oxide synthase and NADPH oxidase expression in endothelial cells. Arterioscler Thromb Vasc Biol 23: 38-44, 2003.
14. Hendel MD, Collister JP. Contribution of the subfornical organ to angiotensin II-induced hypertension. Am J Physiol Heart Circ Physiol 288: H680-H685, 2005.
15. Hong MK, Romm PA, Reagan K, Green CE, Rackley CE. Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal women. Am J Cardiol 69: 176-178, 1992.
16. 1 receptor binding and mRNA in the female rat. Brain Res 844: 34-42, 1999.
17. Komesaroff PA, Black CV, Westerman RA. A novel, nongenomic action of estrogen on the cardiovascular system. J Clin Endocrinol Metab 83: 2313-2316, 1998.
18. Komesaroff PA, Esler MD, Sudhir K. Estrogen supplementation attenuates glucocorticoid and catecholamine responses to mental stress in perimenopausal women. J Clin Endocrinol Metab 84: 606-610, 1999.
19. Komesaroff PA, Fullerton M, Dart AM, Jennings GL, Sudhir K. Estrogen supplementation improves vascular reactivity in hypogonadal men. Proc 80th Meeting of the Endocrine Soc. P2-640, 1998.
20. Ma FY, Grattan DR, Bobrovskaya L, Dunkley PR, Bunn SJ. Angiotensin II regulates tyrosine hydroxylase activity and mRNA expression in rat mediobasal hypothalamic cultures: the role of specific protein kinases. J Neurochem 90: 431-441, 2004.
21. Laufs U, Adam O, Strehlow K, Wassmann S, Konkol C, Laufs K, Schmidt W, Bohm M, Nickenig G. Down-regulation of Rac-1 GTPase by estrogen. J Biol Chem 278: 5956-5962, 2003.
22. Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA, Harrison DG. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 95: 588-593, 1997.
23. Lu N, Helwig BG, Fels RJ, Parimi S, Kenney MJ. Central Tempol alters basal sympathetic nerve discharge and attenuates sympathetic excitation to central ANG II. Am J Physiol Heart Circ Physiol 287: H2626-H2633, 2004.
24. Mendelsohn ME, Kara RH. Molecular and cellular basis of cardiovascular gender differences. Science 308: 1583-1587, 2005.
25. Mendelsohn ME. Protective effects of estrogen on the cardiovascular system. Am J Cardiol 89: 12E-18E, 2002.
26. Mitchell JB, Samuni A, Krishna MC, DeGraff WG, Ahn MS, Samuni U, Russo A. Biologically active metal-independent superoxide dismutase mimics. Biochemistry 29: 2802-2807, 1990.
27. Nishiyama A, Fukui T, Fujisawa Y, Rahman M, Tian RX, Kimura S, Abe Y. Systemic and regional hemodynamic responses to tempol in angiotensin II-infused hypertensive rats. Hypertension 37: 77-83, 2001.
28. Pamidimukkala J, Hay M. 17β-Estradiol inhibits angiotensin II activation of area postrema neurons. Am J Physiol Heart Circ Physiol 285: H1515-H1520, 2003.
29. 1 receptors in the brain. Regul Pept 44: 95-107, 1993.
30. Reid IA. Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am J Physiol Endocrinol Metab 262: E763-E778, 1992.
31. Reis SE, Bhoopalam V, Zell KA, Counihan PJ, Smith AJ, Pham S, Murali S. Conjugated estrogens acutely abolish abnormal cold-induced coronary vasoconstriction in male cardiac allografts. Circulation 97: 23-25, 1998.
32. Reis SE, Holubkov R, Zell KA, Smith AJ, Cohen HA, Feldman MD, Blumenthal RS. Estrogen acutely abolishes abnormal cold-induced coronary constriction in men. Chest 114: 1556-1561, 1998.
33. Rodriguez-Puyol M, Griera-Merino M, Perez-Rivero G, Diez-Marques ML, Ruiz-Torres MP, Rodriguez-Puyol D. Angiotensin II induces a rapid and transient increase of reactive oxygen species. Antioxid Redox Signal 4: 869-875, 2002.
34. Romer W, Oettel M, Droescher P, Schwarz S. Novel "scavestrogens" and their radical scavenging effects, iron-chelating, and total antioxidative activities: delta 8,9-dehydro derivatives of 17 alpha-estradiol and 17 beta-estradiol. Steroids 62: 304-310, 1997.
35. Romer W, Oettel M, Menzenbach B, Droescher P, Schwarz S. Novel estrogens and their radical scavenging effects, iron-chelating, and total antioxidative activities: 17 alpha-substituted analogs of delta 9(11)-dehydro-17 beta-estradiol. Steroids 62: 688-694, 1997.
36. Rosas-Arellano MP, Solano-Flores LP, Ciriello J. Co-localization of estrogen and angiotensin receptors within subfornical organ neurons. Brain Res 837: 254-262, 1999.
37. Schumacker PT. Angiotensin II signaling in the brain: compartmentalization of redox signaling? Circ Res 91: 982-984, 2002.
38. Seshiah PN, Weber DS, Rocic P, Valppu L, Taniyama Y, Griendling KK. Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ Res 91: 406-413, 2002.
39. Strehlow K, Rotter S, Wassmann S, Adam O, Grohe C, Laufs K, Bohm M, Nickenig G. Modulation of antioxidant enzyme expression and function by estrogen. Circ Res 93: 170-177, 2003.
40. Sudhir K, Elser MD, Jennings GL, Komesaroff PA. Estrogen supplementation decreases norepinephrine-induced vasoconstriction and total body norepinephrine spillover in perimenopausal women. Hypertension 30: 1538-1543, 1997.
41. Sudhir K, Komesaroff PA. Cardiovascular actions of estrogens in men. J Clin Endocrinol Metab 84: 3411-3415, 1999.
42. 1 receptor signalling pathways in neurons. Clin Exp Pharmacol Physiol 29: 483-490, 2002.
43. Wagner AH, Schroeter MR, Hecker M. 17β-Estradiol inhibition of NADPH oxidase expression in human endothelial cells. FASEB J 15: 2121-2130, 2001.
44. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 325: 1196-1204, 1991.
45. Wang G, Anrather J, Huang J, Speth RC, Pickel VM, Iadecola C. NADPH oxidase contributes to angiotensin II signaling in the nucleus tractus solitarius. J Neurosci 24: 5516-5524, 2004.
46. Wang G, Drake CT, Rozenblit M, Zhou P, Alves SE, Herrick SP, Hayashi S, Warrier S, Iadecola C, Milner TA. Evidence that estrogen directly and indirectly modulates C1 adrenergic bulbospinal neurons in the rostral ventrolateral medulla. Brain Res 1094: 163-178, 2006.
47. Wassmann S, Baumer AT, Strehlow K, van Eickels M, Grohe C, Ahlbory K, Rosen R, Bohm M, Nickenig G. Endothelial dysfunction and oxidative stress during estrogen deficiency in spontaneously hypertensive rats. Circulation 103: 435-441, 2001.
48. Xue B, Pamidimukkala J, Hay M. Sex differences in the development of angiotensin II-induced hypertension in conscious mice. Am J Physiol Heart Circ Physiol 288: H2177-H2184, 2005.
49. Xue B, Pamidimukkala J, Lubahn DB, Hay M. Estrogen receptor-alpha mediates estrogen protection from angiotensin II-induced hypertension in conscious female mice. Am J Physiol Heart Circ Physiol 292: H1770-H1776, 2007.
50. Zimmerman MC, Davisson RL. Redox signaling in central neural regulation of cardiovascular function. Prog Biophys Mol Biol 84: 125-149, 2004.
51. Zimmerman MC, Dunlay RP, Lazartigues E, Zhang Y, Sharma RV, Engelhardt JF, Davisson RL. Requirement for Rac1-dependent NADPH oxidase in the cardiovascular and dipsogenic actions of angiotensin II in the brain. Circ Res 95: 532-539, 2004.
52. Zimmerman MC, Lazartigues E, Lang JA, Sinnayah P, Ahmad IM, Spitz DR, Davisson RL. Superoxide mediates the actions of angiotensin II in the central nervous system. Circ Res 91: 1038-1045, 2002.
53. Zimmerman MC, Lazartigues E, Sharma RV, Davisson RL. Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Circ Res 95: 210-216, 2004.